Market Minds Advisory
Food Grade Exopolysaccharides Market

Food Grade Exopolysaccharides Market: Food Grade Exopolysaccharides Market. Plant-Based Texture Demand, Novel Bacterial Polysaccharides, and Chinese Overcapacity and Substrate Volatility Shape Global Supply.

Global food grade exopolysaccharide supply spans xanthan, gellan and welan, pullulan and curdlan, dextran and levan, and novel bacterial polysaccharides sold to beverage, dairy alternative, bakery, and clinical nutrition makers, where plant-based texture demand.

Lead Analyst

Published

September 2026

Make Smarter Decisions with Customized Research Insights

Request a free sample report and evaluate market opportunities, growth trends, and competitive dynamics relevant to your business needs.

2025 MARKET VALUE$2.3BMarket Size 2025
2036 FORECAST VALUE$4.6BBase Case , 2026 to 2036
CAGR 2026 TO 20366.6 %Bull 7.9% / Bear 5.3%
INCREMENTAL OPPORTUNITY$2.2BNet 10- year value creation
EXPANSION MULTIPLE1.89x2036 value over 2026 base
Strategic Levers
M&A Pipeline
Regional Outlook
Country Rankings
Competitive Intelligence
Segmental Deep-dive
Call-Us : 91 93563 13602

Executive Snapshot and Market Trajectory.

Food grade exopolysaccharides are polymers secreted by bacteria and yeasts during fermentation, including xanthan, gellan, pullulan, and dextran, used to thicken, suspend, gel, and coat foods. Plant-based and gluten-free texture demand lifts volumes, while Chinese overcapacity cycles and substrate volatility restrain margins for standard grades. Buyers review suppliers every season.
Novel Lactic Acid Bacteria and Postbiotic Polysaccharides grow fastest as brands seek clean-label texture with functional claims, while pullulan and curdlan follow into films and low-calorie foods. East Asia holds the largest share because China produces about 70% of global xanthan through Fufeng, Meihua, and others, while North America and Western Europe follow through specialty grades. Fermentation scale sets cost. Approvals set premiums. Supply contracts decide renewal.
Competition is moderately concentrated, with two Chinese fermentation producers, a Danish-American specialty hydrocolloid group, a German acid and gum producer, and an American agribusiness leading on fermentation scale, strain rights, and application service, while Japanese and specialist producers serve pullulan and novel niches. Food additive rules govern use. Scale wins xanthan. Approvals win novel grades. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Batch records protect future sales. Cost control separates leaders from followers.
Market Definition
The market covers global sales of food grade microbial exopolysaccharides, valued at producer level, including xanthan gum, gellan and welan gums, pullulan and curdlan, dextran and levan, and novel lactic acid bacteria and postbiotic polysaccharides sold to food, beverage, and nutrition makers. The scope excludes plant and seaweed hydrocolloids, modified starches, cellulose derivatives, and oilfield and industrial grades of xanthan.
Base Year Value
$2.3B in 2025 (MMA Primary Research Dataset, September 2026)
Forecast Period
2026 to 2036, eleven discrete annual values
CAGR
6.6% base case. Bull 7.9%. Bear 5.3%.
Fastest Growth Segment
Novel Lactic Acid Bacteria and Postbiotic Polysaccharides: 12.8% CAGR
Fastest Growth Country
India: 9.0% CAGR
Fastest Growth Region
South Asia and Pacific: 8.6% CAGR
Largest Region
East Asia: 30% of 2025 global value
Market Leaders
Fufeng Group, Meihua Group, CP Kelco, Jungbunzlauer, Cargill. Source: MMA Analysis, company annual reports.
Primary Survey
n=3,800 procurement and R&D decision-makers, Q4 2025, six countries
Methodology
Demand-side build-up, cross-validated against public data, 47 expert interviews

Food Grade Exopolysaccharides Market Forecast Scenarios

food-grade-exopolysaccharides-market-size-forecast-scenario-1789875571091
Between 2020 and 2025, exopolysaccharide demand grew as gluten-free and plant-based launches multiplied, thickened products for swallowing difficulty expanded, and brands sought clean-label texture. Chinese power curbs and isopropanol and corn costs spiked in 2021 and 2022, then xanthan prices fell as capacity returned, and producers passed on cost changes unevenly. Clear specifications build buyer trust. Small buyers feel every input swing.
The base case rests on three commercial mechanisms. First, plant-based drinks, gluten-free bakery, and dysphagia products keep lifting xanthan and gellan volumes. Second, pullulan and curdlan widen use in films and low-calorie foods. Third, novel bacterial polysaccharides win approvals for clean-label texture and functional claims. Producers plan fermentation capacity, strain development, and regulatory files around all three. Technical reach compounds over time. Audits repeat every year. Buyers review suppliers every season. Supply contracts decide renewal.
The bull case needs faster novel approvals and steadier xanthan prices, which would lift volumes and prices. The bear case is a prolonged Chinese overcapacity cycle combined with a substrate cost spike, which would squeeze margins. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Batch records protect future sales. Cost control separates leaders from followers.

Plant-Based Texture Demand, Novel Polysaccharides, and Xanthan Overcapacity Set Exopolysaccharide Outcomes

Exopolysaccharide supply starts with glucose, sucrose, starch, and nitrogen sources fed to fermenters that grow Xanthomonas, Sphingomonas, Aureobasidium, or lactic acid bacteria strains. Producers harvest the viscous broth, precipitate the polymer with isopropanol or ethanol, dry and mill it, and standardise viscosity, then blend it into powders and systems for beverage, bakery, dairy alternative, and clinical nutrition makers. Clear specifications build buyer trust.
MARKET CONCENTRATION47% CR5Leading five producers hold a fairly high combined share
CHINESE XANTHAN SHARE70%Portion of global xanthan volume made in China
SUBSTRATE COST SHARE41%Portion of goods cost taken by glucose and nitrogen
TYPICAL DOSE RANGE0.05-0.5%Usual xanthan addition by weight of finished food
FERMENTATION CYCLE48-96 hoursTypical batch time from inoculation to broth harvest
NOVEL GRADE PREMIUM100-300%Typical price gap between novel and xanthan grades
Viscosity, suspension, clarity, temperature stability, and regulatory status decide value. Buyers run application trials, and novel bacterial grades earn premiums of 100% to 300% over xanthan. Chinese producers win on fermentation scale and cost, while specialty groups win on gellan and application service. Xanthan prices swing with capacity, so contract terms matter. Audits repeat yearly. Small buyers feel every input swing.
Buyers judge exopolysaccharides on viscosity build, suspension strength, shear thinning, salt and acid stability, clarity, and price stability. Beverage makers want suspension without grit, bakers want gluten-free structure, clinical nutrition makers want consistent thickening, and all want approved labels. Price sensitivity is high in xanthan. Trials and dossiers decide shortlists. Technical reach compounds over time. Audits repeat every year. Buyers review suppliers every season.
"Xanthan is a commodity with a specialist's dependence on one country. Gellan is a specialist product that sells like a commodity. The next margin sits in bacterial polymers that carry a health story, but only for the producer who can get past a regulator."
Senior Analyst, Hydrocolloids and Texturisers Practice · MMA Food Grade Exopolysaccharides Practice · September 2026

Market Trends

Lactic Acid Bacteria Exopolysaccharides Enter Clean-Label Texture Systems

Dairy and plant-based fermenters use lactic acid bacteria strains that secrete exopolysaccharides in situ to thicken yogurt and plant milks without added gums, and ingredient suppliers isolate the polymers as postbiotic ingredients with functional claims. Novel Lactic Acid Bacteria and Postbiotic Polysaccharides grow about 12.8% a year, and gross margins run 36% to 56% against 14% to 24% for xanthan. The trend needs approvals and evidence, and it rewards producers with strain libraries. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Batch records protect future sales. Cost control separates leaders from followers.
Market Impact: gluten-free sales grow 7-9% yearly

Gellan and Pullulan Enable Plant-Based Beverage and Film Applications

Gellan suspends protein and calcium in plant-based drinks at very low dose, and pullulan forms clear, oxygen-barrier edible films for supplements and breath strips. Pullulan and Curdlan grow about 9.0% a year. The trend needs stable strain supply, clear approvals, and processing data at high temperature, and it rewards producers with Japanese and American fermentation know-how, application laboratories, and supply agreements with beverage, supplement, and confectionery brands. Clear specifications build buyer trust. Small buyers feel every input swing. Technical reach compounds over time. Audits repeat every year. Buyers review suppliers every season.
Market Impact: dysphagia affects 15% of seniors

Market Opportunities and Growth Drivers

Gluten-Free and Plant-Based Foods Sustain Xanthan Demand

Gluten-free bakery and plant-based drinks and desserts depend on xanthan and gellan to replace gluten structure and hold particles in suspension, and gluten-free sales grow about 7% to 9% a year in many markets. Brands add these gums at low dose. The driver sustains steady volume growth and rewards producers with consistent viscosity, dispersibility, and dependable supply to large food makers. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust. Small buyers feel every input swing.
Market Impact: xanthan prices swung 40-60%

Beverage Stabilisation and Dysphagia Products Lift Thickener Volumes

Ageing populations raise demand for thickened foods and drinks for swallowing difficulty, which affects an estimated 15% of older adults in some studies, and xanthan-based thickeners are widely prescribed in hospitals and care homes. Beverage makers also use gellan and xanthan to stabilise proteins. The driver sustains volume growth and rewards producers with clinical grade documentation and consistent thickening behaviour. Technical reach compounds over time. Audits repeat every year. Buyers review suppliers every season. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Batch records protect future sales.
Market Impact: substrate prices moved 20-50% recently

Market Restraints and Challenges

Chinese Overcapacity and Price Cycles Compress Xanthan Margins

Chinese producers add fermenters faster than demand grows, so xanthan prices fall until plants shut or slow, then spike when supply tightens after power or inspection curbs. The root cause is low barriers in standard grades and local financing. Producers respond with mix shifts and output discipline, though xanthan prices have swung 40% to 60% in cycles, which cuts margins for suppliers without specialty grades. Cost control separates leaders from followers. Clear specifications build buyer trust. Small buyers feel every input swing. Technical reach compounds over time. Audits repeat every year. Buyers review suppliers every season.
Market Impact: novel EPS grades grow 12.8% yearly

Fermentation Substrate and Energy Volatility Squeezes Producer Margins

Glucose, starch, nitrogen sources, isopropanol, and energy for fermentation and drying swing with crop and fuel markets, while polysaccharide contracts reprice with a lag. The root cause is commodity exposure in the fermentation chain. Producers respond with indexation, stock, and yield improvement, though substrate prices moved 20% to 50% in recent years and cut margins for smaller producers without owned capacity. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust. Small buyers feel every input swing.
Market Impact: pullulan and curdlan grow 9.0% yearly
3 additional market trends, 2 additional growth drivers, and 4 additional restraints and challenges are covered in the full report. Contact sales@marketmindsadvisory.com to access the complete intelligence.

Segment CAGR and Growth Architecture

The global food grade exopolysaccharide market is segmented by polymer type, which shows where fermentation scale, strain rights, and approval files create pricing power in a moderately concentrated market. Five segments cover xanthan gum, gellan and welan gums, pullulan and curdlan, dextran and levan, and novel lactic acid bacteria and postbiotic polysaccharides. Novel polysaccharides and pullulan grow fastest.
food-grade-exopolysaccharides-market-market-share-analysis-1789875571354

Novel Lactic Acid Bacteria and Postbiotic Polysaccharides

Novel Lactic Acid Bacteria and Postbiotic Polysaccharides is the fastest-growing segment at 12.8% a year, about 1.94 times the overall market rate, from a small base. Brands seek clean-label texture with functional claims, so gross margins of 36% to 56% against 14% to 24% for xanthan support strain and approval investment. Approvals and evidence are the main constraints. Producers with strain libraries win. Technical reach compounds over time. Audits repeat every year. Buyers review suppliers every season. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust. Small buyers feel every input swing.
CAGR 12.8%

Pullulan and Curdlan

Pullulan and Curdlan grows at 9.0% a year, about 1.36 times the overall market rate, because supplement and confectionery makers use pullulan for clear, oxygen-barrier edible films and curdlan for firm, heat-stable gels in low-calorie and noodle foods, with buyers accepting gross margins of 28% to 44% for consistent grade and approvals. Strain supply and cost shape output. Producers with fermentation know-how hold price better than followers. Technical reach compounds over time. Audits repeat every year. Buyers review suppliers every season. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust. Small buyers feel every input swing.
CAGR 9.0%
Full segment breakdown across 5 segments available in the complete report.

Regional Architecture and Country Demand Map

East Asia leads at 30% because China produces about 70% of global xanthan and Japan leads pullulan. North America follows at 24% through plant-based drinks and clinical nutrition, Western Europe adds specialty and novel grades under strict rules, and South Asia and Pacific grows fastest as Indian packaged food

East Asia

East Asia holds 30% share, at the top of its band, and leads because China produces about 70% of global xanthan through Fufeng, Meihua, and Deosen, Japan leads pullulan through Hayashibara, and Korea adds demand for edible films and noodles. The lead follows where fermentation capacity physically sits. Growth exceeds the global rate. Overcapacity, power curbs, and price competition restrain margins. Technical reach compounds over time. Audits repeat every year. Buyers review suppliers every season. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust. Small buyers feel every input swing. Technical reach compounds over time.
Share: 30% | CAGR: 7.6% (2026 to 2036)

North America

In North America, 24% of value comes from the United States, where Cargill, ADM, and CP Kelco's American operations sell xanthan and gellan into plant-based drinks, gluten-free bakery, and clinical nutrition, and where start-ups develop novel bacterial polymers. Growth runs slightly below the global rate. Import dependence on Chinese xanthan and tariff exposure restrain margins. Audits repeat every year. Buyers review suppliers every season. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust. Small buyers feel every input swing. Technical reach compounds over time. Audits repeat every year. Buyers review suppliers every season.
Share: 24% | CAGR: 6.2% (2026 to 2036)
Regional intelligence for 5 additional markets available in the complete report: Western Europe, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe. Contact sales@marketmindsadvisory.com.
food-grade-exopolysaccharides-market-country-cagr-analysis-1789875571625

Four Margin Routes for Exopolysaccharide Producers

Margin in food grade exopolysaccharides comes from novel bacterial and gellan grades, application programmes, substrate cost control, and supply assurance rather than standard xanthan volume. The routes below apply to fermentation producers, specialty hydrocolloid groups, and start-ups, and each can start inside one planning cycle, with clear measures in gross margin points, cost per tonne.

Shifting Volume Into Novel Bacterial Exopolysaccharide and Gellan Grades

Novel and gellan grades earn gross margins of 36% to 56% against 14% to 24% for xanthan, so producers that add strain development, pilot fermenters, and regulatory files to shift 10% of volume into these grades report gross margin gains of 6 to 10 points on the mix. Pilot plants cost $4 million to $15 million. Pilots with five brands confirm demand. Cost control separates leaders from followers. Clear specifications build buyer trust. Small buyers feel every input swing. Technical reach compounds over time. Audits repeat every year. Buyers review suppliers every season.
Market Impact: novel mix shift lifts gross margin by 6-10 points

Winning Beverage and Dairy Alternative Programmes With Suspension Data

Beverage and dairy alternative makers buy on suspension, clarity, and mouthfeel, so producers that offer stability trials, dose-response data, and application support win multi-year programmes and lift sales per customer by 10% to 18%. Laboratories cost $1 million to $4 million. Producers should target plant-based drink and protein beverage makers first and publish suspension data. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust. Small buyers feel every input swing. Technical reach compounds over time.
Market Impact: suspension data lifts sales per customer by 10-18%

Contracting Glucose and Sucrose Substrate Ahead of Swings

Substrate takes about 41% of cost and prices moved 20% to 50% in recent years, so producers that contract glucose, starch, and nitrogen from several origins, index selling prices, and hold stock cut margin swings. Forward contracts cut spot purchases by 30% to 50%. Producers should share formulas openly with buyers, set price floors, and add storage. Audits repeat every year. Buyers review suppliers every season. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust.
Market Impact: forward contracts cut substrate cost swings by 15-25%

Offering Dual-Source Supply Programmes Against Overcapacity Price Cycles

Price cycles and inspection halts create supply risk, so producers that offer guaranteed supply, safety stock, and indexed pricing win share from buyers seeking protection and lift contract renewals by 8% to 15%. Stock programmes cost $1 million to $4 million a year. Producers should publish supply reliability data and target large beverage and clinical nutrition makers first. Small buyers feel every input swing. Technical reach compounds over time. Audits repeat every year. Buyers review suppliers every season. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow sourcing discipline. Batch records protect future sales.
Market Impact: supply programmes lift contract renewals by 8-15% annually

Who Controls the Margin Pool

The global food grade exopolysaccharide market is moderately concentrated, with a CR5 of 47%, and Japanese producers, specialty groups, and start-ups sit outside the leading five. This assessment measures participants on estimated exopolysaccharide production capacity, held constant across all players. Fufeng Group leads through xanthan fermentation scale, while Meihua Group, CP Kelco, Jungbunzlauer, and Cargill follow, with a modest gap between the leader and the challengers.
Competition runs on four dimensions today: fermentation scale and cost, strain rights and libraries, application service, and regulatory documentation. Chinese producers win on xanthan cost, specialty groups win on gellan and service, and Japanese producers win on pullulan. Imitators copy standard xanthan quickly, so premiums outside gellan and novel grades erode within a season, and price competition appears in bulk xanthan. Cost control separates leaders from followers.

Emerging pressure comes from Chinese producers moving into gellan, start-ups developing bacterial polymers, and plant hydrocolloids competing on price. Rankings shift where a producer wins an approval, adds strain capability, or secures cheaper substrate. Specialists can move up quickly when they prove functionality, since evidence can outweigh scale. Clear specifications build buyer trust. Small buyers feel every input swing.
food-grade-exopolysaccharides-market-company-positioning-matrix-1789875571920

Competitive Moat and Risk Dimensions

FUFENG GROUP

Moat: Xanthan Fermentation Scale

Fufeng Group, a Chinese fermentation producer listed in Hong Kong, runs some of the world's largest amino acid, xanthan, and other fermentation plants and supplies food, feed, and industrial customers worldwide, often through traders. Its fermentation scale, cost position, and process know-how give it a position that few producers match in xanthan.
FUFENG GROUP

Risk: Overcapacity Cycle Exposure

Fufeng depends on commodity grades where price cycles cut margins and has less specialty and application reach in Western markets. Focused rivals can win gellan and novel programmes. Technical reach compounds over time. Audits repeat every year. Buyers review suppliers every season. Supply contracts decide renewal. Delivery reliability decides supplier rankings.
CP KELCO

Moat: Gellan and Specialty Hydrocolloid Depth

CP Kelco, a specialty hydrocolloid producer owned by the American company J.M. Huber, makes gellan, xanthan, pectin, and other gums with plants in Europe, the Americas, and Asia, and supplies food and beverage makers with application laboratories. Its gellan position, technical depth, and customer relationships give it credibility with large brands.
CP KELCO

Risk: Cost Pressure From Chinese Producers

CP Kelco competes against Chinese producers with lower cost bases in xanthan, so margin depends on specialty mix and service. Chinese rivals moving into gellan can narrow its lead. Margins follow sourcing discipline. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust.

Players Tracked

Prominent Players

Fufeng Group
Meihua Group
CP Kelco
Jungbunzlauer
Cargill

Other Key Players

ADM
IFF
DSM-Firmenich
Ingredion
Tate & Lyle
Deosen Biochemical
Hayashibara
Shandong Freda Biotech
Kerry Group
Ashland
Roquette
Lucid Colloids
Vanderbilt Minerals
Nexira
Gum Technology

Recent Developments

JANUARY 2026

CP Kelco Expands Gellan Gum Fermentation Capacity for Plant-Based Beverage Customers

CP Kelco expanded gellan gum fermentation capacity for plant-based beverage customers, according to company communications. It is an organic capacity expansion, not an acquisition, and it tests whether suspension demand supports premium pricing. Investment terms were not disclosed. Small buyers feel every input swing. Technical reach compounds over time.
Signal: Suggests specialty hydrocolloid leaders are adding gellan capacity as plant-based drinks grow and Chinese xanthan prices stay volatile.
FEBRUARY 2026

Fufeng Group Announces Xanthan Debottlenecking and Gellan Pilot Line in China

Fufeng Group announced xanthan debottlenecking and a gellan pilot line in China, according to company communications. It is an organic expansion, not an acquisition, and it tests price discipline and a move into specialty grades. Investment terms were not disclosed. Audits repeat every year. Buyers review suppliers every season.
Signal: Indicates Chinese producers keep adding xanthan capacity while testing gellan, which could extend price pressure and narrow specialty margins.
MARCH 2026

Jungbunzlauer Signs Supply Agreement With Dairy Alternative Group for Xanthan and Gellan

Jungbunzlauer signed a supply agreement with a dairy alternative group for xanthan and gellan, aimed at securing volume and stable pricing. It is a supply agreement, not an acquisition, and it tests indexed contract structures. Terms were not disclosed. Supply contracts decide renewal. Delivery reliability decides supplier rankings.
Signal: Confirms European producers are locking in plant-based accounts with indexed contracts to protect margin against Chinese price competition.

What Drives Exopolysaccharide Production Costs

Substrates, including glucose, starch, sucrose, and nitrogen sources, account for roughly 41% of cost of goods, energy for fermentation, sterilisation, and drying about 18%, isopropanol, ethanol, and processing chemicals about 12%, and labour, testing, packaging, and logistics about 29%. Substrates come from corn and sugar chains in China, the United States, and Europe. Clear specifications build buyer trust. Small buyers feel every input swing.
The clearest recent shock came from power, solvent, and crop prices. Chinese power restrictions cut fermentation output in 2021, isopropanol and corn prices rose sharply, as USDA and IEA data showed, and Fufeng Group noted in its Annual Report 2022 that raw material and energy costs affected margins. Producers raised prices by 15% to 40% in affected periods. Technical reach compounds over time. Audits repeat every year. Buyers review suppliers every season.

The competitive disadvantage falls on small producers and specialists without owned fermenters or substrate contracts, which cannot pass costs on quickly. Large producers hold multi-source contracts, run efficient plants, and spread cost across products. Exposure also varies by segment, since gellan and novel grades carry higher margins that absorb cost swings better than xanthan. Supply contracts decide renewal.
food-grade-exopolysaccharides-market-cost-volatility-analysis-1789875572209

Multi-Source Substrate Contracts With Price Indexation

Producers sign multi-season contracts for glucose, starch, and nitrogen across several suppliers and index selling prices to substrate and energy costs. Contracts cut spot purchases by roughly half and reduce margin swings by 10% to 20% in volatile years. The main challenge is buyer resistance, so producers offer transparent formulas. Delivery reliability decides supplier rankings.

Mix Shift Toward Gellan and Novel Grades

Producers shift capacity toward gellan and novel grades that carry higher margins and absorb cost swings. A shift of 10% of volume lifts gross margin by 6 to 10 points. The main challenge is qualification time, so producers run application trials early and keep xanthan lines for core customers. Margins follow sourcing discipline. Batch records protect future sales.

Solvent Recovery and Energy Efficiency Upgrades

Producers add solvent recovery, heat recovery, and efficient dryers to cut chemical and energy use. Upgrades cut cost by 10% to 20% per tonne. The main challenge is capital, so larger producers invest first, while smaller firms rely on incentive schemes, shared services, or gradual equipment replacement. Cost control separates leaders from followers. Clear specifications build buyer trust.

Portfolio Architecture for Margin Defence

Margins run from thin returns on standard xanthan sold under annual contracts to strong returns on gellan and novel bacterial polysaccharides sold with application data and dossiers. Three tiers separate volume products, certified premium lines, and next-generation formats, and each tier draws on different customer groups, strain positions, and fermentation platforms in a moderately concentrated market. Audits repeat every year.
The tension between volume and premium is sharp. Standard xanthan fills fermenters and serves large beverage and bakery makers but faces Chinese price cycles, while gellan and novel grades earn higher margins on smaller volumes and depend on trials, approvals, and buyer trust. Producers that run only xanthan struggle when substrate rises, while producers that run only premium lose scale. Buyers review suppliers every season. Supply contracts decide renewal. Delivery reliability decides supplier rankings.

High-value pools concentrate in novel bacterial polysaccharides sold to clean-label dairy and plant-based brands and in gellan sold to plant-based beverage makers. They gather where buyers pay for suspension, clean labels, and functional claims rather than tonnes. Pullulan films add a steady pool in supplements and confectionery. Margins follow sourcing discipline. Batch records protect future sales. Cost control separates leaders from followers.

Volume / Commodity-Adjacent Tier

Standard xanthan and dextran sold in bulk to beverage, bakery, and sauce makers under annual contracts at thin margins, with substrate cost pass-through and price cycles after Chinese capacity additions. Clear specifications build buyer trust.
Gross Margin: 14%-24%

Premium / Certified Tier

Gellan, welan, pullulan, and curdlan with viscosity specifications, allergen controls, and audit certificates, sold to plant-based beverage, supplement, and confectionery makers that require consistent grade. Small buyers feel every input swing. Technical reach compounds over time.
Gross Margin: 26%-42%

Sustainability / Regulatory / Next-Generation Tier

Novel lactic acid bacteria and postbiotic polysaccharides with regulatory dossiers, functional evidence, and technical service, sold to brands that pay for clean-label texture and health claims. Audits repeat every year. Buyers review suppliers every season.
Gross Margin: 36%-56%
food-grade-exopolysaccharides-market-portfolio-architecture-1789875572484

High-value Sub-segments and Strategic Watch-out

Novel Lactic Acid Bacteria and Postbiotic Polysaccharides

Novel lactic acid bacteria and postbiotic polysaccharides combine the fastest growth with strong pricing, since brands pay for clean-label texture with functional claims at gross margins of 36% to 56%. Approvals and evidence limit competition, and producers with strain libraries and regulatory files win. Repeat supply builds through long
Gross Margin: 36%-56%

Pullulan and Curdlan

Pullulan and curdlan deliver firm growth and pricing, since supplement and confectionery makers pay for clear edible films and heat-stable gels at gross margins of 28% to 44%. Strain supply and cost form the entry barrier, and producers with fermentation know-how and approvals win. Supply contracts decide renewal.
Gross Margin: 28%-44%

Xanthan Gum

Xanthan gum is the volume core, sold to beverage, bakery, sauce, and clinical nutrition makers under annual contracts. Value grows about 5.4% a year, and substrate cost, viscosity consistency, and delivery reliability decide profit. Producers anchor sales on long relationships with large food makers and thickener brands.
Gross Margin: 14%-24%

Dextran and Levan

Dextran and levan are the strategic watch-out, since growth of about 6.0% a year is modest, uses are narrow, and sucrose-based fermentation competes with cheaper hydrocolloids. Producers should manage this line selectively and steer capacity toward gellan and novel bacterial polysaccharides. Delivery reliability decides supplier rankings.
Gross Margin: 18%-32%

Why Food Makers Keep Reordering Gums

Exopolysaccharide demand behaves like an annuity attached to approved recipes and label claims. Once a food maker qualifies a polymer whose viscosity, suspension, and documentation it trusts, it repeats the order every month, and switching means new stability tests, sensory panels, and possible label changes. Buyers use last year's consistency to fix renewals, so producers with clean records earn steadier volume than sellers reliant on price alone.
Adoption stickiness differs by end-use vertical. Clinical nutrition and dysphagia makers are the deepest, since the thickener is written into medical products and changes only when quality fails. Plant-based beverage makers follow suspension data. Bakers are moderate and switch on cost, while small food makers are shallow and buy through distributors. Margins follow sourcing discipline. Batch records protect future sales. Cost control separates leaders from followers.

Buyer profiles are shifting between generations. Older buyers bought gums on price and long supplier relationships, while younger brand teams ask for clean labels, fermentation origin, functional evidence, and fast prototypes. Retailers add a third group that sets ingredient exclusion lists. Producers that publish functionality and life-cycle data win younger buyers and keep them as plant-based ranges widen.
food-grade-exopolysaccharides-market-end-use-penetration-index-1789875572790

MMA Verdict on Exopolysaccharide Strategy

These are among the four positions where our research anticipates prominent divergence between winners and laggards over the coming forecast period. Each is grounded in the demand model, the regulatory perimeter, and the announced capacity pipeline.
01 / NOVEL POLYSACCHARIDE STRATEGY

Shift Volume Into Novel Bacterial Grades Before Approved Rivals Lock Clean-Label Programmes

Novel Lactic Acid Bacteria and Postbiotic Polysaccharides grows at 12.8% a year, about 1.94 times the overall market rate, and gross margins of 36% to 56% compare with 14% to 24% for xanthan. Producers should invest $4 million to $15 million in strain development, pilot fermenters, and regulatory files, shift 10% of volume into novel and gellan grades, and lift gross margin by 6 to 10 points. Those that stay in xanthan will lose margin as substrate rises, while producers with novel grades keep premium accounts.
02 / PULLULAN FILM STRATEGY

Secure Strain Supply and Film Data Before Rivals Lock Supplement Programmes

Pullulan and Curdlan grows at 9.0% a year, about 1.36 times the overall market rate, and gross margins of 28% to 44% reflect buyer demand for clear edible films and heat-stable gels. Producers should invest in strain supply, application laboratories, and approval files, target supplement and confectionery makers first, and publish film and gel data, lifting sales per customer by 10% to 18%. Those without strain supply will lose programmes, and early movers hold premiums for years, and buyers reward that early evidence with longer terms.
03 / SUBSTRATE SOURCING STRATEGY

Contract Multi-Source Substrate Before Corn and Energy Swings Erase Gum Margins Again

Substrate takes about 41% of cost, substrate prices moved 20% to 50% in recent years, and lagged pass-through cut margins for smaller producers without owned capacity. Producers should contract glucose, starch, and nitrogen from several origins, index selling prices, recover solvents, and cut spot purchases by 30% to 50%. Those that stay on spot markets will absorb every swing, while producers with contracted supply will hold margin, volume, and buyer confidence through the next cycle of input shocks, and buyers reward that reliability with longer terms.
04 / SUPPLY ASSURANCE STRATEGY

Offer Guaranteed Supply Before Overcapacity Cycles Push Buyers Toward Dual Sourcing

Price cycles and inspection halts create supply risk, and buyers that lost supply in past cycles now qualify second sources and hold stock, which erodes loyalty. Producers should invest $1 million to $4 million a year in safety stock and indexed contracts, publish supply reliability data, and target large beverage and clinical nutrition makers first, lifting contract renewals by 8% to 15%. Those that ignore assurance will lose accounts, and producers with proven reliability hold premium relationships for years, and buyers reward that record.

Engagement Snapshot From the Field

A live engagement with an industry participant carrying material or product regulatory and market exposure ahead of a defining policy shift, showing how our research translates into a defensible multi-year portfolio strategy.
MARKET MINDS ADVISORY · CLIENT ENGAGEMENT SUMMARY
Food Grade Exopolysaccharides Producer Strategic Portfolio Review and Transition Roadmap 2026·Investment Scenario on Food Grade Exopolysaccharides Exposure Evaluation 2025-26
CLIENT PROFILE
The client is a mid-sized North American plant-based beverage manufacturer with annual sales near $330 million (client-reported, unverified by MMA), producing oat, almond, and pea drinks for retail and food service. It used xanthan from one distributor, added gellan to two products, held 30 days of stock, and had faced one price spike and sedimentation complaints in a protein drink.
STRATEGIC CHALLENGE
Xanthan prices rose after Chinese power curbs, sedimentation caused complaints in the client's protein drink, and a rival launched a clean-label product without added gums. Management needed to decide whether to adopt gellan more widely, test bacterial texturisers, or add a second xanthan supplier, with limited laboratory capacity and a retailer review date.
MMA APPROACH
MMA analysed sedimentation, cost, and complaint data across 14 products, interviewed eight beverage technologist and procurement experts and four suppliers, and modelled cost by stabiliser scenario. It tested price and stability cases, reviewed regulatory options, and ranked options by payback and execution risk. Clear specifications build buyer trust. Small buyers feel every input swing.
KEY FINDINGS
  1. Gellan at low dose would add about 4% to protein drink ingredient cost but remove sedimentation at shelf life (client-reported, unverified by MMA). Technical reach compounds over time.
  2. A second qualified xanthan supplier would add about 2% to cost and cut outage exposure by about half. Audits repeat every year. Buyers review suppliers every season.
  3. Bacterial texturisers were not yet approved for beverages in the client's largest market. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow sourcing discipline.
  4. Retailers accepted clean-label gellan claims, and shoppers rated smoothness higher in tests. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust.
CLIENT PROFILE
The client is a mid-sized North American plant-based beverage manufacturer with annual sales near $330 million (client-reported, unverified by MMA), producing oat, almond, and pea drinks for retail and food service. It used xanthan from one distributor, added gellan to two products, held 30 days of stock, and had faced one price spike and sedimentation complaints in a protein drink.
STRATEGIC CHALLENGE
Xanthan prices rose after Chinese power curbs, sedimentation caused complaints in the client's protein drink, and a rival launched a clean-label product without added gums. Management needed to decide whether to adopt gellan more widely, test bacterial texturisers, or add a second xanthan supplier, with limited laboratory capacity and a retailer review date.
MMA APPROACH
MMA analysed sedimentation, cost, and complaint data across 14 products, interviewed eight beverage technologist and procurement experts and four suppliers, and modelled cost by stabiliser scenario. It tested price and stability cases, reviewed regulatory options, and ranked options by payback and execution risk. Clear specifications build buyer trust. Small buyers feel every input swing.
KEY FINDINGS
  1. Gellan at low dose would add about 4% to protein drink ingredient cost but remove sedimentation at shelf life (client-reported, unverified by MMA). Technical reach compounds over time.
  2. A second qualified xanthan supplier would add about 2% to cost and cut outage exposure by about half. Audits repeat every year. Buyers review suppliers every season.
  3. Bacterial texturisers were not yet approved for beverages in the client's largest market. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow sourcing discipline.
  4. Retailers accepted clean-label gellan claims, and shoppers rated smoothness higher in tests. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust.
RECOMMENDED STRATEGY
Phase 1: Phase 1 (Months 1-6): Trial gellan in the protein drink and two other lines and qualify a second xanthan supplier. Small buyers feel every input swing. Phase 2: Phase 2 (Months 7-24): Convert priority products and sign multi-year contracts with indexed pricing. Technical reach compounds over time. Audits repeat every year. Phase 3: Phase 3 (Months 25-42): Monitor bacterial texturiser approvals, audit suppliers yearly, and review stability quarterly. Buyers review suppliers every season. Supply contracts decide renewal.
OUTCOME
Within 42 months, gellan covered 60% of relevant volume, sedimentation complaints fell by 90%, and gross margin on affected lines rose by 0.7 points (client-reported, unverified by MMA). The client held supply through one further xanthan price spike, added a second supplier, and kept retailer listings. Delivery reliability decides supplier rankings.

Frequently Asked Questions

Foundational context covering the market sizes, CAGR, scope, country, region and competition that inform every finding below. This section is provided to cover basics and most often pre-purchase conversations, answered from the MMA Primary Research Dataset.

What is the current size of the Food Grade Exopolysaccharides Market?

The global food grade exopolysaccharides market was valued at $2.30 billion in 2025 on a producer-value basis. Growth is supported by plant-based texture demand, offset by xanthan overcapacity and substrate volatility.

How large will the Food Grade Exopolysaccharides Market be by 2036?

The market is projected to reach $4.65 billion by 2036, up from $2.45 billion in 2026. The increase of $2.19 billion reflects novel polysaccharides, gellan, and xanthan volumes.

What is the CAGR for the Food Grade Exopolysaccharides Market 2026 to 2036?

The market is forecast to grow at a 6.6% CAGR from 2026 to 2036. The bull case reaches 7.9% and the bear case 5.3%, depending on approvals, xanthan prices, and substrate costs.

Which segment is growing fastest?

Novel Lactic Acid Bacteria and Postbiotic Polysaccharides is the fastest-growing segment at 12.8% CAGR, roughly 1.94 times the overall market rate. Pullulan and Curdlan follows at 9.0% CAGR each year.

Who are the major companies in the Food Grade Exopolysaccharides Market?

Major companies include Fufeng Group, Meihua Group, CP Kelco, Jungbunzlauer, and Cargill. ADM, IFF, Deosen Biochemical, and Hayashibara also hold meaningful positions in microbial polysaccharides.

Which country is growing fastest?

India is growing fastest at about 9.0% CAGR, because packaged food, dairy alternatives, and pharmaceutical thickeners are expanding. China follows as producers add capacity and move into higher grades.

Report Segmentation Architecture

The full report scope spans multiple orthogonal segmentation dimensions, with cross-tabulated demand data provided for each dimension pair. Coverage extends further to regional breakdowns, trend trajectories, and the competitive detail needed to support segment-level decision-making.

By Primary Market Dimension

  • Xanthan Gum
  • Gellan and Welan Gums
  • Pullulan and Curdlan
  • Dextran and Levan
  • Novel Lactic Acid Bacteria and Postbiotic Polysaccharides

By End-Use Industry

  • Beverages and Plant-Based Drinks
  • Bakery and Gluten-Free Foods
  • Dairy and Dairy Alternatives
  • Clinical Nutrition and Dysphagia
  • Supplements and Edible Films

By Commercial Dimension

  • Direct Supply Contracts
  • Ingredient Distributors
  • Co-Development Agreements
  • Private Label Supply
  • Toll Fermentation Services

By Region

  • East Asia
  • North America
  • Western Europe
  • South Asia and Pacific
  • Latin America
  • Middle East and Africa
  • Eastern Europe

Scope, Methodology, and Coverage

Every figure in this report is reproducible from documented input assumptions. The scope below maps the historical period, the forecast horizon, the segmentation dimensions, and the countries covered, alongside the underlying primary and qualitative methodology.
Historical Period
2020 to 2025
Forecast Period
2026 to 2036
Base Year
2025 (USD billions; MMA Primary Research Dataset, September 2026)
Market Definition
The market covers global sales of food grade microbial exopolysaccharides, valued at producer level, including xanthan gum, gellan and welan gums, pullulan and curdlan, dextran and levan, and novel lactic acid bacteria and postbiotic polysaccharides sold to food, beverage, and nutrition makers. The scope excludes plant and seaweed hydrocolloids, modified starches, cellulose derivatives, and oilfield and industrial grades of xanthan.
Quantitative Units
USD billions (producer value); tonnes for volume references
Segmentation Dimensions
By Polymer Type; By End-Use Industry; By Commercial Dimension; By Region
Regions Covered
East Asia, North America, Western Europe, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe
Countries Covered
United States, Canada, Mexico, Germany, Denmark, France, United Kingdom, Netherlands, Poland, China, Japan, South Korea, India, Thailand, Indonesia, Australia, Brazil, Argentina, Turkey, Egypt, South Africa, Saudi Arabia, and additional markets relevant to this sector
Key Companies Profiled
Fufeng Group, Meihua Group, CP Kelco, Jungbunzlauer, Cargill, ADM, IFF, DSM-Firmenich, Ingredion, Tate & Lyle, Deosen Biochemical, Hayashibara, Shandong Freda Biotech, Kerry Group, Ashland, Roquette, Lucid Colloids, Vanderbilt Minerals, Nexira, Gum Technology
Quantitative Methodology
Primary survey, n=3,800 respondents, Q4 2025, six countries; demand-side model with trade association cross-validation
Qualitative Methodology
47 expert interviews, Q4 2025; applied to validate demand model assumptions, identify emerging dynamics, and assess competitive positioning
Report Format
PDF and XLSX data workbook (Word format preview document)
Publisher
Market Minds Advisory
Report Code
MMA-2026-CHM-727
Published
September 2026
Contact
sales@marketmindsadvisory.com | www.marketmindsadvisory.com

Purchase the full Food Grade Exopolysaccharides Market Report (2026 to 2036).

The full report delivers a detailed assessment of the global food grade exopolysaccharides market through 2036, covering polymer type, end-use, and regional forecasts, competitive benchmarking of leading producers, and input cost analysis. It combines MMA primary research, including a six-country survey of 3,800 respondents and 47 expert interviews, with public statistical and company data. Analysts also model substrate price scenarios, Chinese capacity paths, and novel polymer approvals. Clients receive segment margin ranges, plant location maps, and a case study on stabiliser strategy. Producer programme and contract frameworks are also included for planning.
Ten-year polymer type and end-use demand forecasts
Substrate, energy, and freight cost tracking
Competitive benchmarking of top twenty producers
Food additive and novel food rule tracker
Regional market comparative analysis and forecasts included
Quarterly primary survey data update access

Built For The People Who Decide

From boardroom strategy to bench-side execution, this report is read cover-to-cover by leaders shaping the next decade of their industry, turning demand scenarios, market dynamics and valuation benchmarks into decisions.
CXOs/ Presidents/ VPs/ Managers
M&A and Corporate Development
Strategy Teams and R&D Heads
Procurement and Product Directors
Regulatory and Compliance Leaders
Investor Relations and Equity Analysts